Skip to main content
. 2022 Mar 8;46(6):855–865. doi: 10.4093/dmj.2021.0264

Fig. 2.

Fig. 2

Comparative analysis of varying glycosylated hemoglobin (HbA1c, %) levels during 42 months in different groups (efficacy set total vs. antidiabetic drug maintenance vs. antidiabetic drug change). Values are presented as HbA1c mean (number of patients).